•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
ERNODASA
Composition:
Per capsule:
Streptokinase................................10,000 I.U.
Streptodornase................................2,500 I.U.
Excipients: Lactose, magnesium stearate, talc, gelatine, titanium dioxide (E
171), indigotin (E 132) and azorubin (E 122).
Indications:
Treatment of inflammatory processes in which there are collections of blood
and/or fibrinous and purulent exudates.
Dosage:
1 capsule every 6 hours for 4 to 6 days.In acute cases, greater doses can be used
as attack therapy.Maximum therapeutic dose: 2 capsules 4 times a day.
Warning:
"Warnings about excipients"
This medicine contains azorubin as an excipient. It may cause allergic reactions,
including asthma especially in patients allergic to acetylsalicylic acid.
Contraindications:
ERNODASA is contraindicated for patients with active hemorrhagic processes,
or who have some deficiency in hemostasis.
Relative contraindications:Patients with a high risk of hemorrhaging
(hypertensive, hemiplegic, etc.).
Precautions:
In major surgical operations it is advisable not to begin treatment with
ERNODASA until the 7th day following the operation and under suitable
supervision.
Interactions:
Prior treatment with anticoagulants is relatively incompatible. The effect of
heparin can be blocked with protamine sulphate administered prior to treatment
with ERNODASA. Likewise, coumarinic anticoagulants can be neutralized with
vitamin K1 until normalization of the Quick value.
Side effects:
They rarely occur due to the purity of the preparation. Occasionally phenomena
of sensitization may appear in individuals with a high percentage of antistreptokinase and anti-streptodornase antibodies. Treatment consists of
suppressing use of ERNODASA and the usual anti-allergic measures.
Intoxication and its treatment:
The active components of ERNODASA are not toxic "per se". Allergic
reactions, although unusual, are treated in the usual way in these cases
(antihistamines, corticoids).
Storage conditions:
No special storage conditions are required.Keep at room temperature.
Formats and prices:
20-capsule container:
Published price+VAT €3.10. N.C. 942821
40-capsule container:
•
•
•
•
•
•
•
•
•
•
Published price+VAT €5.52. N.C. 653295
Clinical 500-capsule container:
Laboratory price €44.79.Published price+VAT €54.48. N.C. 609073
Prescription and dispensing conditions
By prescription. Eligible for financing by the National Health System.
Reduced price.
ERN LABORATORIES CORP.
Pedro IV, 499 - 08020 Barcelona, Spain